Glenview Capital Management’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,990,247
Closed -$19.3M 63
2017
Q4
$19.3M Sell
1,990,247
-2,227,466
-53% -$16.6M 0.1% 56
2017
Q3
$28.7M Buy
4,217,713
+1,843,000
+78% +$15.7M 0.17% 52
2017
Q2
$27.7M Buy
2,374,713
+375,000
+19% +$3.7M 0.18% 49
2017
Q1
$16.7M Hold
1,999,713
0.11% 50
2016
Q4
$15.7M Hold
1,999,713
0.11% 48
2016
Q3
$20.4M Hold
1,999,713
0.15% 48
2016
Q2
$22.6M Hold
1,999,713
0.16% 41
2016
Q1
$24.7M Hold
1,999,713
0.18% 41
2015
Q4
$23.8M Buy
1,999,713
+287,100
+17% +$3.72M 0.13% 53
2015
Q3
$27M Buy
+1,712,613
New +$34.7M 0.13% 73

Other funds holding KND

Glenview Capital Management's KND Position: Q1 2018 in Review

Glenview Capital Management sold out of Kindred Healthcare (KND) in Q1 2018, closing a stake of 1,990,247 shares — an estimated $19.3M sold.

Glenview Capital Management first reported a position in KND in Q3 2015 and held it in 10 quarters. The position peaked at $28.7M in Q3 2017. 166 funds tracked by Wall St. Rank hold KND as of Q1 2018.

  • Glenview Capital Management reported no remaining Kindred Healthcare position as of Q1 2018 after selling out during the quarter.
  • Glenview Capital Management sold 1,990,247 Kindred Healthcare shares in Q1 2018, an estimated $19.3M.
  • Glenview Capital Management first reported a position in Kindred Healthcare in Q3 2015 and held it in 10 quarters.
  • Glenview Capital Management's Kindred Healthcare position peaked at $28.7M in Q3 2017.
  • 166 funds tracked by Wall St. Rank held Kindred Healthcare as of Q1 2018.

Based on Glenview Capital Management's 13F filing for Q1 2018, filed 15 May 2018.